Partial reprogramming deep dive: the good, bad, and partially unresolved — Ada Nguyen
adanguyenx.com · 13,113 words · saved by 1 readers
A deep dive into all scientific literature in the field and companies working on partial reprogramming.
Partial reprogramming deep dive: the good, bad, and partially unresolved Last updated: May 4th, 2023 Right now, partial reprogramming is the hottest topic in longevity. The field went from being overlooked to becoming one of the most well-funded research areas after billions of dollars in investment into projects like NewLimit (Brian Armstrong) and Altos Labs (Yuri Milner, Jeff Bezos). But how promising is it exactly? I decided to spend a few months learning all I could in an attempt to answer that question (see detailed notes on all the papers I’ve read here ). This deep dive is a culmination
related reading
- Nintil - Aging is already solved in vitro. What comes next?nintil.com
- Longevity FAQ - Laura Demingldeming.com
- A primer on the current state of longevity researchowlposting.com
- Epigenetic reprogramming of cell identity: lessons from development for regenerative medicineclinicalepigeneticsjournal.biomedcentral.com
- Nintil - The Longevity FAQnintil.com
- Nintil - Beyond lifespan as a metric in aging research: why reprogramming is promisingnintil.com
- Bottlenecks of Aging - Amaranth Foundationamaranth.foundation
- Anti-Aging: State of the Art — LessWronglesswrong.com
- What we wish we knew entering the aging fieldlibrariesforthefuture.bio
- What the Aging Field Needs - Celine Haliouacelinehh.com
- The Hallmarks of Agingncbi.nlm.nih.gov
- Andrew Brack (@BrackLab) on Xx.com